These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17726264)

  • 1. Overexpression of gastrin-releasing peptide receptors in tumor-associated blood vessels of human ovarian neoplasms.
    Fleischmann A; Waser B; Reubi JC
    Cell Oncol; 2007; 29(5):421-33. PubMed ID: 17726264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14).
    Reubi JC; Wenger S; Schmuckli-Maurer J; Schaer JC; Gugger M
    Clin Cancer Res; 2002 Apr; 8(4):1139-46. PubMed ID: 11948125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applications.
    Fleischmann A; Waser B; Reubi JC
    Endocr Relat Cancer; 2009 Jun; 16(2):623-33. PubMed ID: 19478282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant vascular GRP-receptor and VEGF-receptor expression in human tumors: molecular basis for dual targeting of tumoral vasculature.
    Reubi JC; Fleischmann A; Waser B; Rehmann R
    Peptides; 2011 Jul; 32(7):1457-62. PubMed ID: 21605611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast.
    Gugger M; Reubi JC
    Am J Pathol; 1999 Dec; 155(6):2067-76. PubMed ID: 10595936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers.
    Sun B; Schally AV; Halmos G
    Regul Pept; 2000 Jun; 90(1-3):77-84. PubMed ID: 10828496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrin-releasing peptide receptors in normal and neoplastic human uterus: involvement of multiple tissue compartments.
    Fleischmann A; Waser B; Gebbers JO; Reubi JC
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4722-9. PubMed ID: 15941862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.
    Markwalder R; Reubi JC
    Cancer Res; 1999 Mar; 59(5):1152-9. PubMed ID: 10070977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215.
    Engel JB; Keller G; Schally AV; Halmos G; Hammann B; Nagy A
    Clin Cancer Res; 2005 Mar; 11(6):2408-15. PubMed ID: 15788692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective in vitro targeting of GRP and NMB receptors in human tumours with the new bombesin tracer 177Lu-AMBA.
    Waser B; Eltschinger V; Linder K; Nunn A; Reubi JC
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):95-100. PubMed ID: 16909223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrin releasing peptide-preferring bombesin receptors mediate growth of human renal cell carcinoma.
    Pansky A; DE Weerth A; Fasler-Kan E; Boulay JL; Schulz M; Ketterer S; Selck C; Beglinger C; VON Schrenck T; Hildebrand P
    J Am Soc Nephrol; 2000 Aug; 11(8):1409-1418. PubMed ID: 10906154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bombesin receptors in distinct tissue compartments of human pancreatic diseases.
    Fleischmann A; Läderach U; Friess H; Buechler MW; Reubi JC
    Lab Invest; 2000 Dec; 80(12):1807-17. PubMed ID: 11140694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts.
    de Visser M; van Weerden WM; de Ridder CM; Reneman S; Melis M; Krenning EP; de Jong M
    J Nucl Med; 2007 Jan; 48(1):88-93. PubMed ID: 17204703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
    Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
    Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
    Breeman WA; de Jong M; Erion JL; Bugaj JE; Srinivasan A; Bernard BF; Kwekkeboom DJ; Visser TJ; Krenning EP
    J Nucl Med; 2002 Dec; 43(12):1650-6. PubMed ID: 12468515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro binding evaluation of 177Lu-AMBA, a novel 177Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues.
    Thomas R; Chen J; Roudier MM; Vessella RL; Lantry LE; Nunn AD
    Clin Exp Metastasis; 2009; 26(2):105-19. PubMed ID: 18975117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression.
    Halmos G; Wittliff JL; Schally AV
    Cancer Res; 1995 Jan; 55(2):280-7. PubMed ID: 7812958
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.